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Abstract A wild type keratin 9 (K9) cDNA and a point mutated
keratin 9 cDNA were injected subcutaneously into mouse skin.
The hemagglutinin tag staining of the wild type K9 cDNA
injected specimens mainly showed a homogeneous pattern,
whereas the point mutated K9 cDNA injected specimens mainly
showed a granular pattern in the suprabasal cells. Double
staining of K9 and the endogenous keratin revealed the
incorporation of de novo synthesized K9 into the keratin
network. These results demonstrate that (1) a naked DNA
transfection into mouse skin can detect the pathogenic changes of
point mutated keratin in vivo and (2) the keratin 9 mutation
disrupts the keratin network formation in the suprabasal cells in
vivo.
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1. Introduction
Keratins are the major structural proteins of the epidermis
[1]. The 10 nm keratin ¢laments belong to the intermediate
¢lament superfamily. All the intermediate ¢laments have a
central K-helical domain, the rod, which is £anked by a
non-helical head and tail domain. Keratins assemble in vitro
as obligatory heteropolymers. The highly conserved rod ends
play a crucial role in intermediate ¢lament network forma-
tions [2^4]. A point mutation in the keratin perturbs the ker-
atin ¢lament structure, causing hereditary diseases of the skin
[3^8], such as an epidermolytic palmoplantar keratoderma [8^
14]. Several methods have been proposed for detecting the
e¡ect of pathogenicity caused by the point mutation seen in
hereditary diseases such as epidermolysis bullosa simplex and
epidermolytic hyperkeratosis. There are two types of assays in
vitro to detect the e¡ect of such point mutations. The trans-
fection of the wild type and point mutated human keratin
cDNA into cells [15], and the reconstitution of the keratin
¢lament with or without the point mutated keratin, are meth-
ods to detect the pathogenic changes of point mutation in
vitro [16]. While transgenic mice with mutant keratin cDNA
have been used to demonstrate change of the keratin ¢lament
structure in vivo [8], much work is needed to construct trans-
genic mice. In naked DNA transfection, the skin is a useful
target because it is accessible and easily monitored for the
presence and expression of a gene [17,18]. The direct trans-
fection of a gene into the skin is possible by needle injection
[19,20], and the direct injection of a naked plasmid DNA into
the cutaneous is a simple and direct in vivo technique for
introducing and expressing a gene in the epidermis [20]. We
found a G to A transition in the K9 gene, resulting in the
substitution of glutamine for arginine in all patients with a
pedigree of epidermolytic palmoplantar keratoderma, and re-
ported that the K9 point mutation seen in such patients was
responsible for the pathogenicity in transfected cultured cells
with a degenerative change of the keratin intermediate ¢la-
ment structure [8]. We have tested whether the functional
change can be detected by naked DNA transfection in vivo.
Two types of naked DNA plasmids, normal K9 cDNA and
point mutated K9 cDNA, were injected subcutaneously into
mice. Here we demonstrate that a point mutation in K9
causes the e¡ect of pathogenicity in the upper epidermal
layers in vivo.
2. Materials and methods
2.1. Expression vectors
Expression vectors were constructed as described previously [8]. In
short, the pCMX-HA contained a cytomegalovirus promoter, a he-
magglutinin protein of in£uenza (HA) tag and a SV40 poly(A) signal.
A normal human K9 cDNA was inserted into the pCMX-HA to
construct the plasmid pCMX-K9HA. The plasmid pCMX-
K9R162QHA has a point mutated K9 cDNA existing in the epider-
molytic palmoplantar keratoderma patient. These plasmid DNAs
were puri¢ed by a⁄nity chromatography (Qiagen, Chatsworth, CA,
USA) followed by column chromatography with Bio-Gel 150 (Bio-
Rad, Boston, MA, USA). Plasmid DNAs were suspended in distilled
water and stored at 320‡C.
2.2. Animals and gene transfer
Non-pregnant hairless mice were purchased from Shimizu Co. Ltd.
(Kyoto, Japan). With a 1 ml syringe and a 30 gauge needle, hairless
mice were injected subcutaneously with 20 Wg of each plasmid DNA
in a total volume of 50 Wl daily for 3 days. Five days after the ¢rst
injection, the injected skin was removed and frozen immediately in
OCT Compound (Sakura Finetechnical, Tokyo, Japan), cut into 6 Wm
thick sections and air dried for 30 min. Sections were rinsed with
phosphate bu¡ered saline (PBS) and processed for immunostaining.
2.3. Cells and transfection
Madin-Darby canine kidney cells (MDCK cells) were grown in
Dulbecco’s MEM supplemented with 10% fetal calf serum (FCS)
and 100 U/ml penicillin and 100 Wg/ml streptomycin. MDCK cells
were grown on glass coverslips in 6-well plates (Iwaki, Kyoto, Japan).
The cells were transfected with plasmid DNA using Lipofectamine
reagent (Gibco-BRL, Bethesda, MD, USA) according to the distrib-
utor’s recommendation. At 24 h after transfection, cells were ¢xed in
3% paraformaldehyde for 10 min and permeabilized by incubation
with 0.5% Triton-X for 10 min. Transfected cells were then processed
for immunostaining.
2.4. Immuno£uorescence
To detect transfected cells, an anti-HA mouse monoclonal antibody
(clone 12CA5) (Boehringer Mannheim, Indianapolis, IN, USA) was
used to recognize the HA tag as a primary antibody and a £uorescein-
conjugated goat IgG fraction to mouse IgG (Organon Teknika, NC,
USA) was used as a secondary antibody. Sections were incubated at
room temperature with a primary antibody (1:400 dilution) for 60
min, rinsed, subsequently incubated with a secondary antibody
(1:120 dilution) for 60 min, rinsed again, and ¢nally mounted with
PPD-glycerin (p-phenylenediamine-glycerin). The following antibodies
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Fig. 1. Confocal laser microphotographs of double-immuno£uorescent colocalization of the HA tag and endogenous keratins. MDCK cells
were transfected with pCMX-K9HA (A^C) and pCMX-K9R162QHA (D^F). Mouse skin was injected with pCMX-K9HA (G^I) and pCMX-
K9R162QHA (J^L). The red color of 543 nm laser light demonstrates the localization of K9HA product (A,G) or K9R162QHA product (D,J)
while the green of 488 nm demonstrates endogenous keratins (B,E,H,K). C, F, I and L show the superpositioning of colocalization through
overlaying of the 488 nm and 543 nm light.
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were used for further double staining studies. In MDCK cell staining,
a 1:400 diluted anti-HA.11 rabbit polyclonal antibody (Berkeley Anti-
body, CA, USA) and a 1:100 diluted rhodamine-conjugated swine
anti-rabbit IgG (Dakopatts, Glostrup, Denmark) was used for the
HA tag staining. Subsequently endogenous keratin network of
MDCK cells were stained with a 1:1000 diluted MAB1629 (mouse
monoclonal anti-cytokeratin 5, 8; Chemicon, CA, USA) and a 1:100
diluted £uorescein-conjugated goat IgG fraction to mouse IgG (Orga-
non Teknika, NC, USA). To examine the expression of HA and
keratin in naked DNA transfected mice skin sections the following
antibodies were used: a 1:400 diluted anti-HA mouse monoclonal
antibody, a 1:120 diluted rhodamine-conjugated swine anti-mouse
IgG (Dakopatts, Glostrup, Denmark), a 1:10 diluted rabbit anti-cy-
tokeratin (Zymed Laboratories, CA, USA) and a 1:120 diluted £uo-
rescein-conjugated swine anti-rabbit IgG (Dakopatts, Glostrup, Den-
mark). All sections were observed with a Carl Zeiss LSM 410 confocal
laser scanning microscope.
2.5. HE stain analysis
After the immuno£uorescence study, slides were incubated with
10% formalin for 3 days. The coverslips were removed and rinsed
with PBS. The sections were stained with hematoxylin for 1 min,
rinsed with tap water and stained with eosin for 7 min.
3. Results and discussion
The phenotypic changes of naked DNA transfected epider-
mal cells were compared with the DNA transfected culture
cells. We transfected the wild type K9 cDNA (pCMX-
K9HA) or the point mutated K9 cDNA (pCMX-
K9R162QHA) into MDCK cells and performed an analysis
by double staining with a confocal laser scanning microscope
using 488 nm and 543 nm laser light. The red signal (HeNe
543 nm laser) in Fig. 1 demonstrates the staining on the tag
sequence (HA) derived from transfected pCMX-K9HA (Fig.
1A,G) and pCMX-K9R162QHA (Fig. 1D,J) cDNAs and the
green signal (argon 488 nm laser) shows the endogenous ker-
atin network by the keratin staining (Fig. 1B,E,H,K). As
shown by the red signal, the K9 protein showed droplet for-
mation in the mutant K9 transfectant cells (Fig. 1D), whereas
it showed the ¢lament formation in the wild type cDNA
transfected cells (Fig. 1A). The specimens for the naked
DNA transfection showed essentially the same results. The
wild type transfectants mainly showed a homogeneous stain-
ing pattern (Fig. 1G), while the mutant transfectants mainly
exhibited a granular pattern (Fig. 1J). In cultured cells, both
the ¢lament and droplet formation of endogenous keratin
were observed in the mutant transfectant (Fig. 1E). In the
endogenous keratin staining of the specimens subjected to
naked DNA transfection, there was no di¡erence between
pCMX-K9HA (wild type) and pCMX-K9R162QHA (point
mutated type) (Fig. 1H,K), moreover, there was no di¡erence
between the transfectant and the non-transfectant. These ob-
servations suggest that disruption of internal keratin is not
detectable with a single staining by keratin in vivo. The ability
of K9 to integrate into the endogenous keratin network was
examined by superpositioning because a dominant-negative
e¡ect of the mutant keratin is thought to be the pathomecha-
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Fig. 2. Confocal laser microphotographs reveal localization of pCMX-K9HA and pCMX-K9R162QHA DNA products by staining with the
anti-HA tag. The mice injected with the pCMX-K9HA mainly showed a homogeneous pattern (A) while those given pCMX-K9R162QHA
mainly showed a granular pattern (C). The same samples were reused for the HE stain for the microscopic observation. There were no mor-
phological changes (B,D).
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nism of an epidermolytic palmoplantar keratoderma, i.e. the
incorporation of de novo synthesized mutant keratin is needed
to disrupt the keratin ¢lament network. We performed an
analysis by using 488 nm and 543 nm laser light. In cultured
cells the yellow colored ¢lament formation in Fig. 1C clearly
demonstrates the colocalization of pCMX-K9HA product and
endogenous keratin. Similarly the yellow droplet formation
in Fig. 1F demonstrates the colocalization of pCMX-
K9R162QHA product and the endogenous keratin, indicating
de novo synthesized K9 ¢lament integrated into the endoge-
nous keratin network. Specimens of the naked DNA trans-
fection revealed similar results. The yellow in pCMX-K9HA
and pCMX-K9R162QHA transfectant cells indicates that
exogenous DNA products were integrated into the endoge-
nous keratin ¢laments (Fig. 1I,L). However, in addition to
the granules of yellow signal (Fig. 1L, arrow), those of red
signal (Fig. 1L, arrowhead) were observed in pCMX-
K9R162QHA transfectant, indicating that newly synthesized
K9R162QHA products are not completely integrated in the
endogenous keratins (Fig. 1L) in vivo. These results show that
the naked DNA transfection assay can detect pathogenic
change to the same degree as the transfected cell culture assay
by staining with HA, and at the point mutated K9 integrates
endogenous keratin network not only in the basal cell layer
but also in the suprabasal cell layer.
To test the relationship between the granule formation in
the immunostaining and HE staining, wild type K9 cDNA
(pCMX-K9HA), point mutated K9 cDNA (pCMX-
K9R162QHA) and negative control plasmid without K9 se-
quence (pCMX-HA) were injected subcutaneously into mice
at days 1, 2 and 3. Although an epidermolytic palmoplantar
keratoderma with the K9 point mutation is clinically charac-
terized by a di¡use thickening of palmar and plantar epider-
mis [21,22], there was no clinical change in the skin of mice at
day 5. As shown in Figs. 1 and 2 by immuno£uorescence
detection, expression of the exogenous DNA in the keratino-
cyte occurred only once to several in each specimen which
may re£ect low e⁄ciency of DNA uptake in the keratinocyte
and may re£ect no clinical change in the skin. There are no
naked DNA uptake in ¢broblast.
The immuno£uorescence study revealed that the specimens
injected with the pCMX-K9HA plasmid and pCMX-HA
(data not shown) mainly showed a homogeneous pattern of
expression (Fig. 2A) and those injected with the pCMX-
K9R162QHA plasmid a granular pattern (Fig. 2C). The
same samples were subjected to hematoxylin eosin staining
(HE stain) for microscopic observation. Fig. 2B,D shows
the HE stains of specimens corresponding to Fig. 2A,C. No
morphological changes such as individual cell keratinization
were observed in the £uorescence positive cells, suggesting
that there was no cell damage caused by the aggregation of
the keratin intermediate ¢laments. After the HE stain analy-
sis, we subjected the samples to ultrastructural analysis by
transmission electron microscopy, but were unable to observe
any clear changes in keratin intermediate ¢laments such as
clear vacuolated areas in their cytoplasm or clumps of coarse
tono¢laments (data not shown) [22], because samples had
been badly damaged by the immuno£uorescence and HE stain
analysis.
The staining ratio of each pattern was determined through
the detection of the HA tag derived from the pCMX-K9HA
and pCMX-K9R162QHA cDNAs. The pCMX-HA showed
66.7% (18.7 þ 9.0; mean þ S.D. is cells per HA positive cells)
homogeneous (H) and 33.3% (9.3 þ 6.8) granular (G) staining.
The pCMX-K9HA showed 62.6% (20.7 þ 1.6) H and 37.4%
(12.3 þ 4.1) G patterned staining. The pCMX-K9R162QHA
showed 37.5% (13.0 þ 3.6) H and 62.5% (21.7 þ 5.7) G staining
(Table 1). Thus, pCMX-K9HA injected specimens showed
twice the number of H than G. Reciprocally, pCMX-
K9R162QHA injected specimens revealed twice number of
G than H. These results show that the point mutated K9
cDNA a¡ected the keratin intermediate ¢lament assembly.
Our results revealed that naked DNA transfection into
mouse skin produced an e¡ect of pathogenicity similar to
that in transfected cultured cells, and the K9R162Q mutation
caused the aggregation of the keratin intermediate ¢lament in
vivo.
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